Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 2008, Volume 38, Issue 1, pp. 1 - 12
Objectives We had the impression and preliminary evidence that atherosclerosis was not much increased in Behçet's syndrome (BS). Thus, we evaluated the...
Rheumatology | Behçet's syndrome | atherosclerosis | B-mode ultrasonography | intima-media thickness | femoral artery | atherosclerotic plaques | carotid artery | Behcet's syndrome | C-REACTIVE PROTEIN | SYSTEMIC-LUPUS-ERYTHEMATOSUS | ACCELERATED ATHEROSCLEROSIS | CAROTID-ARTERY | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | RHEUMATOID-ARTHRITIS PATIENTS | CORONARY-HEART-DISEASE | CARDIOVASCULAR RISK-FACTORS | CHRONIC-RENAL-FAILURE | Humans | Middle Aged | Behcet Syndrome - complications | Carotid Artery Diseases - diagnosis | Adult | Atherosclerosis - complications | Female | Femoral Artery | Male | Evaluation | Rheumatoid factor | Proteolipids | Lipoproteins | Antirheumatic agents | Rheumatoid arthritis | Atherosclerosis | Universities and colleges | Blood lipoproteins
Rheumatology | Behçet's syndrome | atherosclerosis | B-mode ultrasonography | intima-media thickness | femoral artery | atherosclerotic plaques | carotid artery | Behcet's syndrome | C-REACTIVE PROTEIN | SYSTEMIC-LUPUS-ERYTHEMATOSUS | ACCELERATED ATHEROSCLEROSIS | CAROTID-ARTERY | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | RHEUMATOID-ARTHRITIS PATIENTS | CORONARY-HEART-DISEASE | CARDIOVASCULAR RISK-FACTORS | CHRONIC-RENAL-FAILURE | Humans | Middle Aged | Behcet Syndrome - complications | Carotid Artery Diseases - diagnosis | Adult | Atherosclerosis - complications | Female | Femoral Artery | Male | Evaluation | Rheumatoid factor | Proteolipids | Lipoproteins | Antirheumatic agents | Rheumatoid arthritis | Atherosclerosis | Universities and colleges | Blood lipoproteins
Journal Article
Diabetes Care, ISSN 0149-5992, 05/2004, Volume 27, Issue 5, pp. 1077 - 1080
Orlistat Augments Postprandial Increases in Glucagon-like Peptide 1 in Obese Type 2 Diabetic Patients Taner Damci , MD 1 , Serap Yalin , MD 1 , Huriye Balci ,...
METFORMIN | GLP-1 | SECRETION | ENDOCRINOLOGY & METABOLISM | Diabetes Mellitus - blood | Single-Blind Method | Obesity | Glucagon-Like Peptide 1 | Protein Precursors - blood | Humans | Middle Aged | Diabetes Mellitus - drug therapy | Gastric Inhibitory Polypeptide - blood | Male | Insulin - blood | Glucagon - blood | Anti-Obesity Agents - therapeutic use | Lactones - therapeutic use | Cross-Over Studies | Diabetes Mellitus, Type 2 - blood | Weight Loss | Peptide Fragments - blood | Orlistat | Adult | Female | Aged | Type 2 diabetes | Care and treatment | Glucagon | Insulin resistance | Research | Health aspects | Drugs | Hormones | Diabetes | Peptides
METFORMIN | GLP-1 | SECRETION | ENDOCRINOLOGY & METABOLISM | Diabetes Mellitus - blood | Single-Blind Method | Obesity | Glucagon-Like Peptide 1 | Protein Precursors - blood | Humans | Middle Aged | Diabetes Mellitus - drug therapy | Gastric Inhibitory Polypeptide - blood | Male | Insulin - blood | Glucagon - blood | Anti-Obesity Agents - therapeutic use | Lactones - therapeutic use | Cross-Over Studies | Diabetes Mellitus, Type 2 - blood | Weight Loss | Peptide Fragments - blood | Orlistat | Adult | Female | Aged | Type 2 diabetes | Care and treatment | Glucagon | Insulin resistance | Research | Health aspects | Drugs | Hormones | Diabetes | Peptides
Journal Article
Cardiology in the Young, ISSN 1047-9511, 10/2010, Volume 20, Issue 5, pp. 547 - 554
Objective: Studies show that anti-epileptic drugs increase oxidative stress. Thus, low-density lipoprotein oxidation increases and atherogenesis is induced....
valproic acid | paraoxanase | oxidised low-density lipoprotein | Carbamazepine | arterial distensibility | HUMAN SERUM PARAOXONASE | HOMOCYSTEINE | CARDIAC & CARDIOVASCULAR SYSTEMS | THYROID-HORMONE | VALPROATE | VASCULAR SMOOTH-MUSCLE | HYPOTHYROIDISM | THYROTROPIN | ANTICONVULSANT DRUGS | PEDIATRICS | ASSOCIATION | Aryldialkylphosphatase - blood | Prognosis | Follow-Up Studies | Oxidation-Reduction | Atherosclerosis - chemically induced | Humans | Risk Factors | Anticonvulsants - therapeutic use | Child, Preschool | Male | Epilepsy - physiopathology | Vascular Resistance - physiology | Atherosclerosis - blood | Anticonvulsants - adverse effects | Adolescent | Epilepsy - drug therapy | Female | Aryldialkylphosphatase - drug effects | Retrospective Studies | Oxidative Stress - drug effects | Child | Lipoproteins, LDL - blood | Epilepsy - blood
valproic acid | paraoxanase | oxidised low-density lipoprotein | Carbamazepine | arterial distensibility | HUMAN SERUM PARAOXONASE | HOMOCYSTEINE | CARDIAC & CARDIOVASCULAR SYSTEMS | THYROID-HORMONE | VALPROATE | VASCULAR SMOOTH-MUSCLE | HYPOTHYROIDISM | THYROTROPIN | ANTICONVULSANT DRUGS | PEDIATRICS | ASSOCIATION | Aryldialkylphosphatase - blood | Prognosis | Follow-Up Studies | Oxidation-Reduction | Atherosclerosis - chemically induced | Humans | Risk Factors | Anticonvulsants - therapeutic use | Child, Preschool | Male | Epilepsy - physiopathology | Vascular Resistance - physiology | Atherosclerosis - blood | Anticonvulsants - adverse effects | Adolescent | Epilepsy - drug therapy | Female | Aryldialkylphosphatase - drug effects | Retrospective Studies | Oxidative Stress - drug effects | Child | Lipoproteins, LDL - blood | Epilepsy - blood
Journal Article
Clinical and Applied Thrombosis/Hemostasis, ISSN 1076-0296, 08/2009, Volume 15, Issue 4, pp. 454 - 457
Hemostatic complications are one of the leading causes of mortality in cancer patients. In the present study, we assessed the hemostatic parameters and...
anticardiolipin antibodies | fibrinogen | D-dimer | PERIPHERAL VASCULAR DISEASE | cancer | HEMATOLOGY | coagulation | Immunoglobulin G - blood | Fibrin Fibrinogen Degradation Products - metabolism | Humans | Middle Aged | Prothrombin Time | Male | Antibodies, Anticardiolipin - blood | Case-Control Studies | Young Adult | Immunoglobulin M - blood | Neoplasms - blood | Blood Coagulation Disorders - immunology | Hemostasis | Neoplasms - immunology | Partial Thromboplastin Time | Adolescent | Fibrinogen - metabolism | Blood Coagulation Disorders - blood | Adult | Female | Aged | Blood Coagulation Disorders - diagnosis
anticardiolipin antibodies | fibrinogen | D-dimer | PERIPHERAL VASCULAR DISEASE | cancer | HEMATOLOGY | coagulation | Immunoglobulin G - blood | Fibrin Fibrinogen Degradation Products - metabolism | Humans | Middle Aged | Prothrombin Time | Male | Antibodies, Anticardiolipin - blood | Case-Control Studies | Young Adult | Immunoglobulin M - blood | Neoplasms - blood | Blood Coagulation Disorders - immunology | Hemostasis | Neoplasms - immunology | Partial Thromboplastin Time | Adolescent | Fibrinogen - metabolism | Blood Coagulation Disorders - blood | Adult | Female | Aged | Blood Coagulation Disorders - diagnosis
Journal Article
Advances in Therapy, ISSN 0741-238X, 5/2007, Volume 24, Issue 3, pp. 560 - 570
In the study reported here, investigators explored the following: (1) the effects of inhaled corticosteroid (ICS) therapy on insulin sensitivity (IS) (the...
inhaled corticosteroid therapy | insulin sensitivity | Medicine & Public Health | Rheumatology | Internal Medicine | Oncology | asthma | Cardiology | Pharmacology/Toxicology | Endocrinology | COPD | Inhaled corticosteroid therapy | Insulin sensitivity | Asthma | MEDICINE, RESEARCH & EXPERIMENTAL | HOMEOSTASIS MODEL ASSESSMENT | LIPID-METABOLISM | CARBOHYDRATE | RISK | BECLOMETHASONE DIPROPIONATE | GLUCOSE | RESISTANCE | PHARMACOLOGY & PHARMACY | Prospective Studies | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Insulin Resistance | Administration, Inhalation | Bronchodilator Agents - pharmacology | Male | Asthma - drug therapy | Budesonide - pharmacology | Adolescent | Adult | Female | Aged | Budesonide - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy
inhaled corticosteroid therapy | insulin sensitivity | Medicine & Public Health | Rheumatology | Internal Medicine | Oncology | asthma | Cardiology | Pharmacology/Toxicology | Endocrinology | COPD | Inhaled corticosteroid therapy | Insulin sensitivity | Asthma | MEDICINE, RESEARCH & EXPERIMENTAL | HOMEOSTASIS MODEL ASSESSMENT | LIPID-METABOLISM | CARBOHYDRATE | RISK | BECLOMETHASONE DIPROPIONATE | GLUCOSE | RESISTANCE | PHARMACOLOGY & PHARMACY | Prospective Studies | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Insulin Resistance | Administration, Inhalation | Bronchodilator Agents - pharmacology | Male | Asthma - drug therapy | Budesonide - pharmacology | Adolescent | Adult | Female | Aged | Budesonide - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
DIABETES CARE, ISSN 0149-5992, 11/2004, Volume 27, Issue 11, pp. 2771 - 2771
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.